Multimodality Imaging and Immune‐Related Adverse Events During Immune Checkpoint Inhibitors Treatment: Where Do We Stand?

Echocardiography, Год журнала: 2025, Номер 42(3)

Опубликована: Март 1, 2025

Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy, significantly improving survival across various malignancies. However, these therapies are associated with types of immune-related adverse events (irAEs), including cardiotoxicity, a spectrum rare but potentially life-threatening complications impacting morbidity and mortality. Cardiovascular imaging has become key in cardio-oncology, providing essential diagnostic tools for early detection monitoring. This review synthesizes current evidence underlines the pivotal role tailored strategies managing ICI-induced cardiotoxicity. By bridging knowledge gap, it aims to provide targetable insights optimize clinical management patients undergoing immunotherapy.

Язык: Английский

Metformina em Combinação Com Inibidores de Checkpoints Imunológicos: A Captação Miocárdica de FDG Pode Prever o Prognóstico?

ARQUIVOS BRASILEIROS DE CARDIOLOGIA - IMAGEM CARDIOVASCULAR, Год журнала: 2025, Номер 38(1)

Опубликована: Март 13, 2025

Metformin in Combination with Immune Checkpoint Inhibitors: Myocardial FDG Uptake Can Predict Prognosis?

ARQUIVOS BRASILEIROS DE CARDIOLOGIA - IMAGEM CARDIOVASCULAR, Год журнала: 2025, Номер 38(1)

Опубликована: Янв. 1, 2025

Язык: Английский